Stay updated on Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Sign up to get notified when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.

Latest updates to the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page
- Check7 days agoChange DetectedSite revision log updated: added Revision v3.4.3 and removed Revision v3.4.2.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedAn added system revision note: Revision: v3.4.2. A funding-status notice and an older Revision: v3.4.1 were removed. These are administrative updates and do not alter the trial's core details or user-facing functionality.SummaryDifference0.3%

- Check43 days agoChange DetectedA general notice about government funding delays was added and the page revision shows v3.4.1 replacing v3.4.0 — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check50 days agoChange DetectedAdded a glossary toggle and updated site metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed the previous QC label ('Last Update Submitted that met QC Criteria'), the lowercase 'data' label, and Revision: v3.3.4.SummaryDifference0.2%

- Check64 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 in the page footer; no changes to core study content such as title, conditions, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check86 days agoChange DetectedLocations section updated with new site entries across multiple countries (California, Connecticut, Illinois, Ohio, Oregon, Pennsylvania, Italy, New Zealand, Eastern Cape, Turkey). Revision tag updated to v3.3.3.SummaryDifference1.0%

Stay in the know with updates to Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of Factor VIIa Variant (813d) in Hemophilia Clinical Trial page.